US Patent

US10016407 — Pharmaceutical compositions and methods of using the same

Method of Use · Assigned to Genus Lifesciences Inc · Expires 2037-02-07 · 11y remaining

Vulnerability score 62/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects novel pharmaceutical compositions including cocaine hydrochloride and methods of treating patients using those compositions.

USPTO Abstract

Novel pharmaceutical compositions including cocaine hydrochloride and methods of treating patients using those pharmaceutical compositions are described.

Drugs covered by this patent

cocaine-hydrochloride (COCAINE HYDROCHLORIDE)

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-2225`	—	cocaine-hydrochloride
`U-2329`	—	cocaine-hydrochloride

Patent Metadata

Patent number: US10016407
Jurisdiction: US
Classification: Method of Use
Expires: 2037-02-07
Drug substance claim: No
Drug product claim: No
Assignee: Genus Lifesciences Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.